---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-073736"
form_type: "8-K"
ticker: "IRWD"
cik: "0001446847"
company_name: "IRONWOOD PHARMACEUTICALS INC"
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:47:52.478310+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Ironwood shareholders elect nine directors, approve executive pay, ratify auditor at 2024 annual meeting

## Summary
- All nine director nominees elected with over 130 million votes each for a one-year term.
- Advisory vote on executive compensation passed with ~127.4 million for, ~8.0 million against.
- Ratification of Ernst & Young as auditor for 2024 approved with ~136.8 million for, ~6.3 million against.
- Meeting held June 18, 2024; all proposals received majority support.

## SEC filing metadata
- accession: 0001104659-24-073736
- form_type: 8-K
- ticker: IRWD
- cik: 0001446847
- company_name: IRONWOOD PHARMACEUTICALS INC
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446847/000110465924073736/0001104659-24-073736-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446847/000110465924073736/tm2417654d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-073736
- JSON: https://secwatch.observer/filing/0001104659-24-073736.json
- Plain text: https://secwatch.observer/filing/0001104659-24-073736.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
